News of Bahrain
World17 February 20222 min read

First woman ‘cured’ of HIV after stem cell transplant

Reuters | Washington The Daily Tribune – www.newsofbahrain.com An American research team reported that it has possibly cured HIV in a woman for the first time. Building on past successes, as well as failures, in the HIV-cure research field, these scientists used a cutting-e

Editorial Team Legacy

Published 17 February 2022, 8:00 · Updated 21:26

Link copied
First woman ‘cured’ of HIV after stem cell transplant

Reuters | Washington

The Daily Tribune – www.newsofbahrain.com

An American research team reported that it has possibly cured HIV in a woman for the first time.

Building on past successes, as well as failures, in the HIV-cure research field, these scientists used a cutting-edge stem cell transplant method that they expect will expand the pool of people who could receive similar treatment to several dozen annually.

Their patient stepped into a rarified club that includes three men whom scientists have cured, or very likely cured, of HIV.

Researchers also know of two women whose own immune systems have, quite extraordinarily, apparently vanquished the virus.

Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, one of the multiple divisions of the National Institutes of Health that funds the research network behind the new case study, told NBC News that the accumulation of repeated apparent triumphs in curing HIV “continues to provide hope.”

“It’s important that there continues to be a success along this line,” he said.

In the first case of what has ultimately been deemed a successful HIV cure, investigators treated the American Timothy Ray Brown for acute myeloid leukemia, or AML.

He received a stem cell transplant from a donor who had a rare genetic abnormality that grants the immune cells that HIV targets natural resistance to the virus.

Join the conversation

Sign in to leave a comment. Every comment is reviewed before it goes live.

No comments yet. Start the conversation.